MiR‐93 is a tumor oncogenic microRNA that has been associated with ophthalmological studies focusing on diabetic retinopathy or glaucoma via experimenting on VEGF‐related pathways (Fuchs et al., 2020). The gene discussed is VEGFA; the disease is neoplasm.